Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America
The study, completed in Latin America, characterizes the clinical-pathological features and outcomes of patients with recurrent or metastati…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Study of Ward Admissions for Haematuria
This clinical trial update shows a study on ward admissions for patients with haematuria that is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
This clinical trial update discusses neuropathy associated with enfortumab vedotin in people with urothelial carcinoma, and the study is cur…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers [Phase 1]
Adaptimmune's Phase 1 trial of MAGE-A10 CAR T therapy for urothelial carcinoma, head and neck cancer, and melanoma has completed.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours [Phase 1]
Phase 1 study evaluating AVA6000 in solid tumors, assessing safety, pharmacokinetics, and early efficacy; recruitment is ongoing across seve…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer
Pfizer-sponsored real-world study protocol evaluating initial treatment patterns and outcomes in patients with advanced or metastatic bladde…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer [Phase 3]
Phase 3 study evaluating durvalumab with chemotherapy, durvalumab plus tremelimumab with chemotherapy, or chemotherapy alone in patients wit…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 [Phase 1]
Phase 1 study GO44010 evaluates RO7496353 in combination with a checkpoint inhibitor (with or without standard chemotherapy) in locally adva…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Circulating Tumor DNA Response In Urothelial Cancer [Phase 2]
A Phase 2 clinical trial updating on circulating tumor DNA response in urothelial carcinoma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of selinexor and pembrolizumab in cisplatin-ineligible or cisplatin-refractory locally advanced…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma [EARLY_Phase 1]
This early-phase trial is evaluating memory-like natural killer (NK) cell therapy in patients with renal cell carcinoma and urothelial carci…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: SYS6002 vs PADCEV in Patients With Advanced Urothelial Carcinoma [Phase 2]
A Phase 2 trial is planned to compare SYS6002 with PADCEV (enfortumab vedotin) in adults with advanced urothelial carcinoma; the study is no…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Association Between the SPHERTEST in Vitro Test and Response to Checkpoint Inhibitor Treatments in Patients With Advanced or Metastatic Urothelial Carcinoma
This clinical trial explores whether SPHERTEST in vitro results correlate with responses to checkpoint inhibitor therapy in patients with ad…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy [NA]
This is an update on a clinical research study (NCT04623502) investigating kidney and urothelial tumor metabolism in patients undergoing sur…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma [Phase 1]
A Phase 1 trial evaluating a triple combination of tremelimumab, durvalumab, and belinostat in urothelial carcinoma; the study is currently …
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer [Phase 1]
The document reports an ongoing Phase 1 trial evaluating cabozantinib in combination with Enfortumab Vedotin for locally advanced or metasta…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) [Phase 1, Phase 2]
This is a clinical trial update for MORPHEUS-UC, a Phase 1/2 study evaluating multiple immunotherapy-based treatments and combinations in ur…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating cryoablation in combination with pembrolizumab or avelumab for metastatic urothelial carcinoma; the study is comple…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer [Phase 3]
This document reports on an ongoing Phase 3, single-arm study evaluating UGN-104 for low-grade upper urinary tract urothelial carcinoma, wit…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Criteria for Selecting First-line Metastatic Treatment for Patients With Urothelial Carcinoma
This clinical trial outlines criteria for selecting first-line metastatic treatment in patients with urothelial carcinoma and is currently r…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors [Phase 2]
ClinicalTrials.gov update for QUILT-3.055, a Phase 2 study of combination immunotherapies in patients who previously received immune checkpo…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for DECOY20 with or without tislelizumab in adults with advanced solid tumors across Phase 1 and Phase 2. The listed i…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations [Phase 1, Phase 2]
Early-phase clinical update on TYRA-300 showing safety signals and preliminary anti-tumor activity in locally advanced or metastatic urothel…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/2 study of OC-001 in locally advanced or metastatic cancers has been terminated according to its clinical trials registry listing.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs
An ongoing clinical trial in Strasbourg is recruiting to evaluate whether trained sniffer dogs can detect urothelial carcinoma (bladder canc…